Dr. Bender is a Pediatric Oncologist on the Leukemia/Lymphoma Team and Associate Director of the Cardio-Oncology Program at Cincinnati Children’s Hospital Medical Center, and Assistant Professor of Pediatrics at the University of Cincinnati College of Medicine.
Dr. Bender completed his medical degree and Internal Medicine-Pediatrics residency at the University of Michigan, where he also served as Chief Resident and undertook a fellowship in medical education. He completed fellowship in Pediatric Hematology/Oncology at Cincinnati Children’s Hospital, during which he also earned a Master of Science in Clinical and Translational Research through the University of Cincinnati College of Medicine.
Clinically, Dr. Bender’s focus is on caring for adolescents and young adults with hematologic malignancies, with a particular focus on Hodgkin and non-Hodgkin lymphomas. His research centers on cardiotoxicity associated with novel therapies in pediatric oncology, along with strategies to identify childhood cancer survivors at highest risk for late-onset cardiotoxicity.
Jonathan serves as co-chair of the ACTION Network Pediatric Cardio-Oncology Workgroup and as a member of the International Cardio-Oncology Society Pediatric Task Force. Within the Children’s Oncology Group, Jonathan is a member of the Hodgkin Lymphoma Steering Committee, the Myeloid Cardiotoxicity Committee, and the steering committee for LEAP, which is a pilot project focused on revolutionizing follow-up for survivors of childhood Hodgkin lymphoma.